is glp 1 safe for kidneys SGLT2 vs GLP-1 CKD: Which Better? GLP-1 agonists in the treatment

Theiss HD, Brenner C, Engelmann MG, Zaruba MM, Huber B, Henschel V, Mansmann U, Wintersperger B, Reiser M, Steinbeck G, et al: Safety and efficacy of SITAgliptin plus GRanulocyte-colony-stimulating factor in patients suffering from Acute Myocardial Infarction (SITAGRAMI-Trial)rationale, design and first interim analysis

DNA double strand breaks: a common theme in neurodegenerative diseases

In that sense, estrogens also appear to have a protective role in PD progression and treatment response (Saunders-Pullman et al., 1999

Mitochondrial dysfunction: a key player in brain aging and diseases

Earlier litigation involving Victoza and other incretin mimetics included claims that the drug was linked to pancreatic cancer, pancreatitis, and other serious conditions, and some of these claims were consolidated in federal court, though many were dismissed or resolved years ago